These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27319951)

  • 1. Correlation Between Severity Index and Quality of Life Index in Patients With Psoriasis Assessed Before and After Phototherapy.
    Couto MI; Carneiro S; Niemeyer-Corbellini JP; Yoshio JH; Ramos-E-Silva M
    Skinmed; 2016; 14(2):93-7. PubMed ID: 27319951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies.
    Mattei PL; Corey KC; Kimball AB
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):333-7. PubMed ID: 23425140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI).
    Hägg D; Sundström A; Eriksson M; Schmitt-Egenolf M
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):452-6. PubMed ID: 24911993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of pioglitazone plus phototherapy versus phototherapy in patients with plaque type psoriasis: a Double Blinded Randomized Controlled Trial.
    Ghiasi M; Ebrahimi S; Lajevardi V; Taraz M; Azizpour A
    J Dermatolog Treat; 2019 Nov; 30(7):664-667. PubMed ID: 30394148
    [No Abstract]   [Full Text] [Related]  

  • 5. Narrow-band UVB Phototherapy does not Consistently Improve Quality of Life in Psoriasis Patients: A Prospective Observational Study from Eastern India.
    Arora S; Kar BR
    Indian Dermatol Online J; 2018; 9(6):394-404. PubMed ID: 30505778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the validity and response distribution of the simplified psoriasis index in patients receiving phototherapy.
    Meah N; Alsharqi A; Azurdia RM; Owens LC; Parslew R; Chularojanamontri L
    Australas J Dermatol; 2018 Feb; 59(1):41-47. PubMed ID: 27730628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis: correlation between severity index (PASI) and quality of life index (DLQI) in patients assessed before and after systemic treatment.
    Silva MF; Fortes MR; Miot LD; Marques SA
    An Bras Dermatol; 2013; 88(5):760-3. PubMed ID: 24173182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Narrowband ultraviolet B phototherapy improves the quality of life in patients with psoriasis.
    Al Robaee AA; Alzolibani AA
    Saudi Med J; 2011 Jun; 32(6):603-6. PubMed ID: 21666943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal barrier and oxidative stress parameters improve during in 311 nm narrow band UVB phototherapy of plaque type psoriasis.
    Darlenski R; Hristakieva E; Aydin U; Gancheva D; Gancheva T; Zheleva A; Gadjeva V; Fluhr JW
    J Dermatol Sci; 2018 Jul; 91(1):28-34. PubMed ID: 29610017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologics and dermatology life quality index (DLQI) in the Australasian psoriasis population.
    Norris D; Photiou L; Tacey M; Dolianitis C; Varigos G; Foley P; Baker C
    J Dermatolog Treat; 2017 Dec; 28(8):731-736. PubMed ID: 28489479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.
    Chaptini C; Quinn S; Marshman G
    Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clear or almost clear skin improves the quality of life in patients with moderate-to-severe psoriasis: a systematic review and meta-analysis.
    Puig L; Thom H; Mollon P; Tian H; Ramakrishna GS
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):213-220. PubMed ID: 27739123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between quality of life and the severity of psoriasis in Turkey.
    Çakmur H; Derviş E
    Eur J Dermatol; 2015 Apr; 25(2):169-76. PubMed ID: 25655046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study.
    Noe MH; Wan MT; Shin DB; Armstrong AW; Duffin KC; Chiesa Fuxench ZC; Kalb RE; Menter A; Simpson EL; Takeshita J; Tyring SK; Van Voorhees AS; Mehta NN; Gelfand JM
    J Am Acad Dermatol; 2019 Oct; 81(4):923-930. PubMed ID: 31163241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a far erythemogenic dose of narrow-band ultraviolet B phototherapy in chronic plaque-type psoriasis.
    Akaraphanth R; Kittipavara Y; Voravutinon N; Wachiratarapadorn U; Gritiyarangsan P
    J Dermatol; 2010 Feb; 37(2):140-5. PubMed ID: 20175848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dramatic impact of a Psoriasis Area and Severity Index 90 response on the quality of life in patients with psoriasis: an analysis of Japanese clinical trials of infliximab.
    Torii H; Sato N; Yoshinari T; Nakagawa H;
    J Dermatol; 2012 Mar; 39(3):253-9. PubMed ID: 22211581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep quality and other patient-reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open-label Phase IIIB trial.
    Strober BE; Sobell JM; Duffin KC; Bao Y; Guérin A; Yang H; Goldblum O; Okun MM; Mulani PM
    Br J Dermatol; 2012 Dec; 167(6):1374-81. PubMed ID: 22897348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome.
    Barrea L; Macchia PE; Di Somma C; Napolitano M; Balato A; Falco A; Savanelli MC; Balato N; Colao A; Savastano S
    J Transl Med; 2016 May; 14(1):130. PubMed ID: 27165166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between PASI and FDLQI in paediatric psoriasis, and treatments used in daily clinical practice.
    Kim E; Fischer G
    Australas J Dermatol; 2021 May; 62(2):190-194. PubMed ID: 33586132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, prospective, observational study examining the impact of risk factors, such as BMI and waist circumference, on quality of life improvement and clinical response in moderate-to-severe plaque-type psoriasis patients treated with infliximab in routine care settings of Greece.
    Petridis A; Panagakis P; Moustou E; Vergou T; Kallidis P; Mandekou-Lefaki I; Chaidemenos G; Sotiriadis D; Alexopoulou G; Haratsis Y; Antoniou C
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):768-775. PubMed ID: 29356149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.